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Introduction {#s1}
============

In recent years the attention of researchers has been attracted to heart rate variability (HRV) as a sensitive indicator of the heart autonomic control in cardiac surgery patients.^[@R1]^ Lakusic et al^[@R2]^ reported that decreased HRV was associated with increased mortality rate in patients who underwent coronary artery bypass grafting (CABG). In contrast, Milicevic et al^[@R3]^ has shown that decreased HRV after CABG has no prognostic significance. The value of HRV indices in risk stratification of other cardiac surgery patients is understudied.

Blood pressure variability (BPV) is the second main phenomenon in the cardiovascular autonomic control. BPV is primarily due to the vasomotor tone, which is not directly related to the heart control. Some authors have shown the unchanged vasomotor tone assessed by the low-frequency oscillations in BPV during cardiopulmonary bypass (CPB).^[@R4]^ However, the mechanisms of this adaptation require a better understanding. In our previous studies we have used the index of synchronization between the low-frequency oscillations in HRV and photoplethysmographic waveform variability (PPGV) for the assessment of the quality of interaction between the baroreflex control of heart rate and peripheral vascular resistance.^[@R5]^ This approach can also be used for studying the cardiovascular adaptation in on-pump cardiac surgery patients.

Cardiac reperfusion injury is the main complication after the following cardioplegic arrest in cardiac surgery patients.^[@R6]^ Various approaches have been developed to eliminate the ischemic component of cardioplegia.^[@R7],[@R8]^ However, to the best of our knowledge, there are no studies on changes in cardiovascular autonomic control in different on-pump cardiac surgery patients (for example, after CABG or correction of valvular heart disease). A priori hypothesis of our study stated that variants of on-pump cardiac surgery (in the present study, CABG or correction of valvular heart disease), differing from one another in the features of the surgical procedures (cardioplegia, CPB time, etc.; see section "Surgical approach") and the patients' baseline clinical status, may have different impact on short-term cardiovascular autonomic control. Studying this question has a potential clinical significance for the personal cardiovascular risk assessment in cardiac surgery patients.

Thus, our aim was to perform a comparative study of short-term cardiovascular autonomic control in cardiac surgery patients who underwent CABG or surgical correction of valvular heart disease (SCVHD).

Materials and Methods {#s2}
=====================

Study design {#s2-1}
------------

We studied 78 on-pump cardiac surgery patients (28 women) aged 59.8±11.8 years (mean ± standard deviation). 42 cardiac surgery patients (12 women) aged 61.8±8.6 years who underwent CABG, and 36 patients (16 women) aged 54.2±14.9 years who underwent SCVHD.

Patients with abnormalities in heart rate impeding the analysis of HRV, severe heart failure, cardiomyopathy, endocrine pathology except compensated diabetes, cancer, organic diseases in the brain and the nervous system, mental illness, abnormalities in peripheral microcirculation, and symptomatic hypertension were excluded from the study.

All the patients underwent clinical examination, electrocardiography, echocardiography, and blood test.

Surgical approach {#s2-2}
-----------------

The standard operative technique was applied to all the patients using CPB (on-pump).

On-pump CABG was conducted on a beating heart, that is, in the parallel perfusion and normothermia, without aortic cross clamping and the use of cardioplegic solution. CPB was performed through the aortic cannulation and installing a single two-stage cannula into the right atrium through the free wall. As the conduits, the left internal thoracic artery (or sometimes the internal thoracic artery from the right side), radial artery, and great saphenous vena were used. To stabilize the myocardium at the coronary anastomoses formation stage, the vacuum stabilizers of the myocardium "Octopus" (Medtronic, USA) or "Acrobat" (Maquet, Germany) were used. All the patients after the completion of CABG, in the absence of contraindications, underwent intraoperative graft angiography in order to assess the quality of formed anastomoses. The surgery was finished in a standard way using drainage of the pericardial cavity and the anterior mediastinum and stratified suturing wounds of the chest.

On-pump SCVHD was conducted in hypothermia and pharmacological cardioplegia. It was carried out through the aortic cannulation, separate cannulation of the superior vena cava using angled cannula, and direct cannulation of the inferior vena cava via the free wall of the right atrium. Cardioplegia was performed antegrade in the aortic root or, in case of the insufficiency of the aortic valve, retrograde through the coronary sinus. For cardioplegia, the cardioplegic solutions Custodiol (Odyssey Pharmaceuticals Inc., Germany) were employed. The surgery was finished in a standard way using drainage of the pericardial cavity and the anterior mediastinum.

The duration of CPB was 73 (56, 98) minutes in patients who underwent CABG and 124 (102, 145) minutes in patients who underwent SCVHD (*P*\<0.001). The data are presented as median with inter-quartile range ([Table 1](#T1){ref-type="table"}). In patients who underwent SCVHD the duration of aortic cross clamping was 65 (57, 75) minutes. None of the patients had signs of perioperative myocardial infarction.

Autonomic control acquisition and processing {#s2-3}
--------------------------------------------

To examine the cardiovascular autonomic control, we carried out the analysis of HRV and estimated the degree of synchronization between the slow oscillations in HRV and PPGV.

The synchronous 15-minutes records of R-R interval (RRI) time series of heart rate and photoplethysmogram (PPG) measured on the middle finger of the hand were performed in all patients before surgery and 5-7 days after surgery. The patients were investigated in the morning under spontaneous breathing. All signals were sampled at 250 Hz and digitized at 14 bits. We excluded from the analysis the series with forced inspiration and delays in breathing. For further analysis, only RRIs and PPG records without artifacts, extrasystoles, and considerable trends were exploited.

To estimate the synchronization between the slow oscillations in HRV and PPGV we applied the method proposed by us recently.^[@R5]^ Index *S* defines the relative time (in percents) of synchronization between the considered low-frequency oscillations ([Figure 1](#F1){ref-type="fig"}). We also calculated the following assessments of HRV: heart rate (HR, bmp), standard deviations of normal to normal intervals (SDNN, ms), total power of HRV spectrum (0 to 0.5 Hz) (TP, ms^2^), power of low-frequency (LF, ms^2^; 0.04 to 0.15 Hz) and high-frequency (HF, ms^2^; 0.15 to 0.40 Hz) components of HRV spectrum, the ratio of LF to TP (LF%), the ratio of HF to TP (HF%), the ratio of LF to HF (LF/HF).^[@R9]^ In each patient, we calculated the personal dynamics of these indices after the surgery denoted as ΔS, ΔHR, ΔSDNN, ΔTP, ΔHF%, ΔLF%, and ΔLF/HF. For example, ΔS = S~after\ surgery~ ‒ S~preoperative~).
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Statistical analysis {#s2-4}
--------------------

Continuous variables are reported as medians (Me) with low and upper quartiles (LQ, UQ). Binary data are presented as frequencies and percentages. The obtained estimations were considered statistically significant, if *P* was less than 0.05. For the statistical analysis, the software package Statistica 6.1 (StatSoft Inc., Tulsa, Oklahoma, USA) was used.

We applied the Shapiro--Wilk test to check whether the HRV spectral data are approximately normally distributed. Since these data are non-normal, their further analysis was carried out using nonparametric statistical methods. To compare the continuous variables, we used the Mann--Whitney test. To compare the variables within one patients' group we used the Wilcoxon test. To compare the two proportions, we used two-sided z-test.

To separate the studied patients into groups in accordance with the values of their autonomic indices, we used the cluster analysis (k-means clustering). The following factors (measured before and after the surgery) were considered in the cluster analysis: index S, HR, SDNN, TP, LF, HF, LF%, HF%, and LF/HF. In this analysis personal dynamics of the following indices after the surgery were also included: ΔS, ΔHR, ΔSDNN, ΔTP, ΔHF%, ΔLF%, and ΔLF/HF.

Results {#s3}
=======

Baseline clinical characteristics of patients {#s3-1}
---------------------------------------------

Baseline clinical characteristics of patients are shown in [Table 1](#T1){ref-type="table"}. Patients who underwent CABG had higher values of the following baseline clinical parameters: body mass index, diastolic blood pressure, creatinine, frequencies of prior myocardial infarction, diabetes and hypertension, frequencies of prior percutaneous coronary interventions, frequencies of preoperative treatment with angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, calcium antagonists, and statins. Patients who underwent SCVHD had higher values of left ventricular ejection fraction, CPB time, and frequency of any in-hospital complications (acute coronary syndrome, acute renal failure, cardiac arrest, cardiac reoperation for bleeding, cardiac reoperation other than bleeding, deep sternal wound infection, stroke, and pneumonia). In studied groups, there was no in-hospital mortality.

###### Baseline clinical characteristics of patients in the studied groups

  -------------------------------------------------- ----------------- ---------------------------------- ----------------------------------- -------------------
  **Parameters**                                     **Data format**   **Patients ongoing CABG (n=42)**   **Patients ongoing SCVHD (n=36)**   ***P*** **level**
  Age, y                                             Me (LQ, UQ)       63 (57, 67)                        58 (47, 65)                         0.086
  Male sex                                           No. (%)           30 (71.4%)                         20 (55.6%)                          0.152
  BMI, kg/m^2^                                       Me (LQ, UQ)       29.2 (27.3, 32.9)                  25.6 (23.2, 29.0)                   0.001
  Prior MI                                           No. (%)           30 (71.4%)                         0 (0)                               \<0.001
  Prior stroke                                       No. (%)           2 (4.8%)                           2 (5.6%)                            0.874
  Hypertension                                       No. (%)           40 (95.2%)                         18 (50.0%)                          \<0.001
  Smoking                                            No. (%)           15 (35.7%)                         6 (16.7%)                           0.063
  Diabetes                                           No. (%)           7 (16.7%)                          0 (0)                               0.012
  COPD                                               No. (%)           3 (7.1%)                           0 (0)                               0.107
  Prior PCI                                          No. (%)           8 (19.0%)                          0 (0)                               0.007
  Baseline SBP, mm Hg                                Me (LQ, UQ)       130 (120, 130)                     120 (110, 130)                      0.029
  Baseline DBP, mm Hg                                Me (LQ, UQ)       80 (70, 85)                        78 (70, 80)                         0.014
  Baseline LVEF, %                                   Me (LQ, UQ)       60 (55, 62)                        66 (60, 67)                         0.001
  LVEF in 5-7 days after surgery, %                  Me (LQ, UQ)       59 (54, 64)                        64 (60, 66)                         0.002
  **Preoperative Blood Test**                                                                                                                 
  Creatinine, mg/dL                                  Me (LQ, UQ)       84 (74, 105)                       69 (61, 88)                         0.044
  Glucose, mmol/L                                    Me (LQ, UQ)       5.4 (4.9, 6.2)                     5.0 (4.7, 5.2)                      0.051
  Leukocytes, \*10^9^/mL                             Me (LQ, UQ)       7.4 (6.0, 8.8)                     6.9 (5.4, 7.2)                      0.315
  Lactate, mmol/L                                    Me (LQ, UQ)       0.9 (0.8, 1.3)                     0.8 (0.7, 1.3)                      0.813
  Hematocrit, %                                      Me (LQ, UQ)       41 (38, 44)                        40 (37, 42)                         0.779
  **Previous Treatment**                                                                                                                      
  ACE inhibitors                                     No. (%)           34 (81.0%)                         10 (27.8%)                          \<0.001
  Beta-blockers                                      No. (%)           34 (81.0%)                         8 (22.2%)                           \<0.001
  Statins                                            No. (%)           30 (71.4%)                         8 (22.2%)                           \<0.001
  Diuretics                                          No. (%)           15 (35.7%)                         16 (44.4%)                          0.436
  Calcium antagonists                                No. (%)           10 (23.8%)                         2 (5.6%)                            0.029
  **Treatment After Surgery**                                                                                                                 
  ACE inhibitors                                     No. (%)           36 (85.7%)                         15 (41.7%)                          \<0.001
  Beta-blockers                                      No. (%)           38 (90.5%)                         10 (27.8%)                          \<0.001
  Statins                                            No. (%)           40 (95.2%)\*                       8 (22.2%)                           \<0.001
  Diuretics                                          No. (%)           16 (38.1%)                         12 (33.3%)                          0.661
  Calcium antagonists                                No. (%)           12 (28.6%)                         2 (5.6%)                            0.010
  **Features of Surgery and Postoperative Period**                                                                                            
  Cardioplegia                                       No. (%)           0 (0 %)                            36 (100%)                           \<0.001
  CPB time, minutes                                  Me (LQ, UQ)       73 (56, 98)                        124 (102, 145)                      \<0.001
  ACCT, minutes                                      Me (LQ, UQ)       ―                                  65 (57, 75)                         ―
  PMVT, hours                                        Me (LQ, UQ)       13.5 (9.0, 21.5)                   20.0 (13.0, 25.0)                   0.099
  Length of ICU stay, days                           Me (LQ, UQ)       1.0 (1.0, 1.0)                     1.0 (1.0, 1.0)                      0.606
  Length of hospital stay, days                      Me (LQ, UQ)       7.5 (7.0, 8.0)                     8.0 (7.0, 11.0)                     0.085
  Any in-hospital complication                       No. (%)           7 (16.7%)                          14 (38.9%)                          0.039
  -------------------------------------------------- ----------------- ---------------------------------- ----------------------------------- -------------------

Continuous variables are presented as medians with inter-quartile ranges -- Me (LQ, UQ). Categorical data are presented as frequencies and percentages -- No. (%). \* Significant differences (*P* \< 0.05) from level of similar parameter before surgery.

CABG, coronary artery bypass grafting; SCVHD, surgical correction of valvular heart disease; BMI, body mass index; MI, myocardial infarction; COPD, chronic obstructive pulmonary disease; PCI, percutaneous coronary intervention; SBP, systolic blood pressure; DBP, diastolic blood pressure; LVEF, left ventricular ejection fraction; ACE, angiotensin-converting enzyme; CPB, cardiopulmonary bypass; ACCT, aortic cross clamping time; PMVT, postoperative mechanical ventilation time; ICU, intensive care unit.

Cardiovascular autonomic indices before and after on-pump cardiac surgery {#s3-2}
-------------------------------------------------------------------------

We found no differences (*Р *\> 0.05) in all parameters (preoperative and post-surgery) of cardiovascular autonomic control between both groups of patients (who underwent CABG or SCVHD) except for the preoperative HR ([Table 2](#T2){ref-type="table"}). Preoperative HR was higher in patients who underwent SCVHD (*P*=0.013). We revealed a pronounced variability of most autonomic indices and post-surgical dynamics of these indices in both patient groups (see magnitude of inter-quartile ranges in [Table 2](#T2){ref-type="table"}).

###### Cardiovascular autonomic indices before and in 5-7 days after the cardiac surgery

  ---------------------------------------- ---------------------------------- ----------------------------------- -------------------
  **Parameters**                           **Patients ongoing CABG (n=42)**   **Patients ongoing SCVHD (n=36)**   ***P*** **value**
  **Preoperative Values**                                                                                         
  Index S, %                               24.7 (18.3, 35.2)                  22.5 (13.4, 27.4)                   0.400
  HR, bmp                                  67 (60, 72)                        69 (65, 80)                         0.013
  SDNN, ms                                 34.9 (24.9, 52.3)                  37.7 (28.4, 53.1)                   0.903
  TP, ms^2^                                493 (311, 1247)                    425 (246, 969)                      0.696
  LF, ms^2^                                134 (47, 315)                      135 (83, 248)                       0.570
  HF, ms^2^                                123 (25, 508)                      74 (33, 188)                        0.428
  LF%                                      24.4 (16.5, 34.6)                  29.4 (17.1, 36.9)                   0.653
  HF%                                      21.6 (9.5, 47.0)                   20.2 (11.1, 29.7)                   0.422
  LF/HF                                    1.2 (0.6, 2.7)                     1.4 (0.6, 2.9)                      0.546
  **5-7 Days After the Cardiac Surgery**                                                                          
  Index S, %                               20.3 (10.2, 27.5)                  20.2 (15.5, 28.1)                   0.529
  HR, bmp                                  78 (73, 87)\*                      74 (66, 90)                         0.439
  SDNN, ms                                 15.6 (11.3, 41.0)                  18.0 (11.1, 71.9)                   0.479
  TP, ms^2^                                84 (26, 496)\*                     125 (36, 2735)                      0.326
  LF, ms^2^                                27 (7, 150)                        53 (9, 637)                         0.446
  HF, ms^2^                                11 (5, 201)                        24 (4, 893)                         0.663
  LF%                                      26.6 (18.1, 36.4)                  30.8 (21.8, 39.8)                   0.526
  HF%                                      26.3 (10.8, 46.4)                  23.7 (9.7, 43.4)                    0.637
  LF/HF                                    0.8 (0.5, 3.4)                     1.2 (0.6, 2.9)                      0.586
  **Personal Dynamics of Indices**                                                                                
  ΔS, %                                    -3.1 (-19.0, +5.8)                 +0.5 (-14.2, +6.3)                  0.488
  ΔHR, bpm                                 +13 (+1, +28)                      +3 (-6, +15)                        0.144
  ΔSDNN, ms                                -16.0 (-38.9, +17.6)               -14.9 (-26.1, +6.3)                 0.637
  ΔTP, ms^2^                               -293 (-841, -44)                   -194 (-640, +234)                   0.304
  ΔLF%                                     +3.4 (-12.6, +12.3)                +1.6 (-12.4, +14.9)                 0.977
  ΔHF%                                     -0.5 (-13.8, +9.2)                 +1.7 (-16.8, +24.0)                 0.783
  ΔLF/HF                                   +0.2 (-1.6, +1.1)                  0 (-1.1, +2.5)                      0.532
  ---------------------------------------- ---------------------------------- ----------------------------------- -------------------

Data are presented as medians with inter-quartile ranges -- Me (LQ, UQ). Index S is relative time (in percents) of synchronization between low-frequency oscillations in HRV and PPGV.

\* Significant differences (*P* \< 0.05) from level of similar parameter before surgery.

CABG, coronary artery bypass grafting; SCVHD, surgical correction of valvular heart disease; HR, heart rate; SDNN, standard deviations of normal to normal intervals; TP, total power (0 to 0.5 Hz) of HRV spectrum; LF, power of low-frequency band (0.04 to 0.15 Hz) of HRV spectrum; HF, power of high-frequency (0.15 to 0.40 Hz) band of HRV spectrum; LF%, ratio (in percents) of LF to TP; HF%, ratio (in percents) of HF to TP; LF/HF, ratio of LF to HF; ΔS = S~after\ surgery~ ‒ S~preoperative~; ΔHR = HR~after\ surgery~ ‒ HR~preoperative~; ΔSDNN = SDNN~after\ surgery~ ‒ SDNN~preoperative~; ΔTP = TP~after\ surgery~ ‒ TP~preoperative~; ΔLF% = LF%~after\ surgery~ ‒ LF%~preoperative~; ΔHF% = HF%~after\ surgery~ ‒ HF%~preoperative~; ΔLF/HF = LF/HF~after\ surgery~ ‒ LF/HF~preoperative~.

After cardiac surgery, some indices of HRV (SDNN, TP, LF, and HF) were decreased in most studied patients (see median and quartiles of these indices and their personal dynamics in [Table 2](#T2){ref-type="table"}). In a part of on-pump cardiac surgery patients, we revealed the increase of most HRV indices (see upper quartile of distributions of their personal dynamics in [Table 2](#T2){ref-type="table"}).

Results of cluster analysis {#s3-3}
---------------------------

In the cluster analysis, we divided all studied patients (n=78) into two groups according to the similarity of their cardiovascular autonomic indices (preoperative and post-surgery). The first group (named as Cluster 1) contains 38 patients, while the second group (named as Cluster 2) includes 40 patients. Clinical characteristics and autonomic indices of patients in Clusters 1 and 2 are shown in [Table 3](#T3){ref-type="table"}, in which only statistically significant differences between the Clusters are presented.

###### Clinical characteristics and autonomic indices of patients in the selected clusters

  ------------------------------------ ---------------------- ---------------------- -------------------
  **Parameters**                       **Cluster 1 (n=38)**   **Cluster 2 (n=40)**   ***P*** **value**
  Preoperative hematocrit, %           42 (38, 44)            39 (36, 41)            0.038
  **Preoperative autonomic indices**                                                 
  HR, bpm                              70 (62, 78)            65 (58, 71)            0.046
  TP, ms^2^                            768 (311, 2385)        356 (270, 738)         0.048
  HF, ms^2^                            274 (125, 1127)        34 (21, 73)            \<0.001
  LF%                                  20.4 (14.7, 35.7)      32.3 (21.1, 36.6)      0.047
  HF%                                  40.1 (27.3, 59.4)      10.1 (5.4, 15.6)       \<0.001
  LF/HF                                0.6 (0.3, 1.0)         2.9 (1.9, 4.5)         \<0.001
  **Personal dynamics of indices**                                                   
  ΔHR, bpm                             -1 (-10, +15)          +13 (+4, +24)          0.018
  ΔLF%                                 +7.6 (0, +12.5)        -1.1 (-13.5, +6.9)     0.049
  ΔHF%                                 -14.0 (-24.5, -3.1)    +16.5 (+2.0, +34.1)    \<0.001
  ΔLF/HF                               +0.5 (+0.2, +2.6)      -1.7 (-3.2, -0.4)      \<0.001
  ------------------------------------ ---------------------- ---------------------- -------------------

Data are presented as medians with inter-quartile ranges -- Me (LQ, UQ). We presented only parameters (clinical, autonomic) with statistically significant (*P*\<0.05) differences between the Clusters.

HR, heart rate; SDNN, standard deviations of normal to normal intervals; TP, total power (0 to 0.5 Hz) of HRV spectrum; HF, power of high-frequency (0.15 to 0.40 Hz) band of HRV spectrum; LF%, ratio (in percents) of LF to TP; HF%, ratio (in percents) of HF to TP; LF/HF, ratio of LF to HF; ΔHR = HR~after\ surgery~ ‒ HR~preoperative~; ΔLF% = LF%~after\ surgery~ ‒ LF%~preoperative~; ΔHF% = HF%~after\ surgery~ ‒ HF%~preoperative~; ΔLF/HF = LF/HF~after\ surgery~ ‒ LF/HF~preoperative~.

We found no differences (*Р*\>0.05) in all clinical characteristics (including ratio of patients who underwent CABG or SCVHD, aortic cross clamping time, CBP time, frequency of any in-hospital complications, length of intensive care unit stay and hospital stay, etc.) between Cluster 1 and Cluster 2, except for the preoperative hematocrit (*P*=0.038). In selected Clusters patients also had no differences (*Р*\>0.05) in index *S* (preoperative and post-surgery) and all post-surgery HRV indices. The patients in Cluster 1 had higher values of the following preoperative parameters ([Table 3](#T3){ref-type="table"}): hematocrit, HR, TP, HF, and HF%. The patients in Cluster 2 had higher values of preoperative LF% and LF/HF ratio ([Table 3](#T3){ref-type="table"}).

Discussion {#s4}
==========

The problem of using HRV in risk stratification of cardiac patients is still actual for the modern cardiology.^[@R10]^ The predictive value of some HRV parameters such as SDNN and non-linear indices is well known for the risk assessment in patients after myocardial infarction and patients with left ventricular dysfunction.^[@R11],[@R12]^ However, the impact of HRV indices on the risk stratification and autonomic dysfunction assessment in cardiac surgery patients is not well known yet.

CABG is associated with a noticeably decreased HRV in the early postoperative period. Thus, the long-term predictive value of HRV indices may be lost in patients after CABG.^[@R3],[@R13]^ Nevertheless, some authors reported well post-surgical predictive value of non-linear HRV parameters in patients after CABG.^[@R14],[@R15]^ Changes in the autonomic control of the heart, associated with CABG, lead to unpredictable cardiovascular events during and after surgery.^[@R16],[@R17]^ In particular, the increased HF% and peak point correlation dimension before CABG are associated with postoperative atrial fibrillation.^[@R18]^ These statements are not confirmed by our findings on short-term follow-up in the present study.

In patients with valvular heart disease, the decreased HRV is caused by a dysfunction of ventricular baroreceptors against the background of pressure overload of the right heart.^[@R19],[@R20]^ Surgical correction of valve defect may remove this factor.

We observed a post-surgery decrease of HRV in most on-pump cardiac surgery patients (see SDNN, TP, and their personal dynamics in [Table 2](#T2){ref-type="table"}) which is consistent with other studies.^[@R19]-[@R22]^ These changes in autonomic control are probably due to peculiarities of surgical procedure (anesthesia, CPB time, aortic cross clamping time, cardioplegia, etc.).^[@R21],[@R23],[@R24]^ However, current knowledge about the association between the peculiarities of surgical procedure and post-surgery events caused by the autonomic dysfunction is contradictory.^[@R25]-[@R27]^ Note that in a part of on-pump cardiac surgery patients included in our study, we revealed the increase of HRV (see upper quartile of distributions of ΔSDNN, and ΔTP in [Table 2](#T2){ref-type="table"}) which differs from the results of other authors. We found no association between autonomic control indices and clinical characteristics of patients including the features of surgical procedure (see [Tables 2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}).

Almost all studied preoperative variables (age, body mass index, old myocardial infarction, hypertension, left ventricular ejection fraction, beta-blockers, etc.) can influence HRV.^[@R9]^ However, we did not find associations of differences between patients on preoperative parameters and autonomic indices.

Souza Neto et al^[@R4]^ showed that slow BPV did not change during CPB in patients receiving no preoperative treatment for cardiovascular diseases, in contrast to patients receiving preoperative treatment with angiotensin-converting enzymes and beta-blockers. In our study the patients divided into two groups according to the features of their autonomic status have no differences in drug treatment (see the Section "Results of cluster analysis").

Conventional HRV indices approved by the European Society of Cardiology and the North American Society of Pacing and Electrophysiology ^[@R9]^ do not allow to properly evaluate the dynamics and non-linear properties of cardiovascular autonomic control. Therefore, many authors exploit a non-linear approach to the HRV assessment.^[@R28],[@R29]^ However, HRV allows evaluating only the autonomic control of the heart rhythm. Additional information on cardiovascular autonomic control can be obtained from PPGV characterizing the fluctuations in peripheral blood flow. Slow oscillations in PPGV have potentially important clinical applications for risk stratification and autonomic dysfunction assessment in patients.^[@R30]^ In our previous studies we have shown the clinical efficiency of the analysis of synchronization of low-frequency oscillations in HRV and finger's PPGV for the risk stratification in patients with acute myocardial infarction, and autonomic dysfunction assessment during treatment in hypertensive patients and patients with coronary artery disease.^[@R5],[@R31],[@R32],[@R33]^ In the present study the preoperative and post-surgery distributions of the index of synchronization of slow oscillations in HRV and PPGV were similar in both studied patients' groups ([Table 2](#T2){ref-type="table"}).

We revealed the similar variability of preoperative status of cardiovascular autonomic control and its post-surgical dynamics in patients who underwent CABG and patients who underwent SCVHD (see [Table 2](#T2){ref-type="table"}). The statistically significant difference in preoperative HR between CABG and SCVHD patients (see [Table 2](#T2){ref-type="table"}) does not seem to be clinically significant: 69 (65, 80) in SCVHD vs 67 (60,72) in CABG. The Clusters selected according to the similarity of autonomic control indices were not associated with the type of cardiovascular surgical pathology (see the Section "Results of cluster analysis"). The selected Clusters of on-pump cardiac surgery patients have significant differences in preoperative autonomic control indices, and have no differences in post-surgical level of these indices. In simple terms, 5 to 7 days after on-pump cardiac surgery some patients restored their preoperative cardiovascular autonomic control more completely and some less so. The clinical significance of this fact requires an examination in future studies.

Conclusion {#s5}
==========

We found no differences in preoperative and post-surgery cardiovascular autonomic indices (except for the preoperative HR) between patients who underwent CABG and patients who underwent SCVHD. The revealed variability of cardiovascular autonomic indices in the studied cardiac surgery patients was not associated with their clinical characteristics, features of surgical procedure, and early postoperative outcomes.

Study limitations {#s6}
=================

Our study included only 36 patients who underwent SCVHD and 42 patients who underwent CABG. These groups are rather small. Therefore, we did not use multiple regression to study the short-term cardiovascular autonomic control in cardiac surgery patients. We used only cluster analysis, which somewhat limits our results.

A lack of long-term follow-up and small number of patients are the main limitations for establishing the predictive value of the obtained results on the dynamics of cardiovascular autonomic indices in patients who undergo CABG or SCVHD.

Two studied patient groups (who underwent CABG or SCVHD) differ substantially. Since valvular heart disease and valve surgery have always been associated with cardioplegia use, it remains unclear which of these two factors led to any observed consequences. Note that all patients without cardioplegia were treated for coronary artery disease. But we found no differences in all preoperative and post-surgery cardiovascular autonomic indices between these groups. Since all studied patients underwent on-pump cardiac surgery, we conditionally regarded them as one summary group.

Two additional limitations are characteristic of our study: (*i*) we did not study diurnal variation of cardiovascular autonomic indices; (*ii*) we used short time records of RRIs and PPG.
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